JPH07505368A - 超微小油球体を用いての局部用及び経皮用投与システム - Google Patents
超微小油球体を用いての局部用及び経皮用投与システムInfo
- Publication number
- JPH07505368A JPH07505368A JP5516836A JP51683693A JPH07505368A JP H07505368 A JPH07505368 A JP H07505368A JP 5516836 A JP5516836 A JP 5516836A JP 51683693 A JP51683693 A JP 51683693A JP H07505368 A JPH07505368 A JP H07505368A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- skin
- composition according
- oil
- droplet size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.約0.5〜30%の油性液体の第1の成分、約0.1〜10%の乳化剤の第 2の成分及び0.05〜5%の非イオン性界面活性剤を含むサブミクロンサイズ の液滴を含む調合薬又は化粧品の局所的塗布のための組成物において、この液滴 が0.05〜0.5μmの範囲内の平均液滴寸法を有する組成物であって、より 大きなサイズの液滴をもつ同じ組成物に比較して増強された局所的及び/又は経 皮性の全身的効果を提供する組成物。 2.平均液滴サイズが約0.1〜0.3μmである請求の範囲第1項に記載の組 成物。 3.第1の成分が約8〜12個の炭素という鎖の長さをもつ中鎖トリグリセリド 油、植物油、鉱油、動物性油、その合成誘導体、又はその混合物を含む、請求の 範囲第1項に記載の組成物。 4.第1の成分が約20〜30%の量で存在して粘性組成物を形成する、請求の 範囲第3項に記載の組成物。 5.乳化剤がリン脂質化合物又はリン脂質の混合物である、請求の範囲第1項に 記載の組成物。 6.リン脂質がレシチン、ホスファチジルコリン、ホスファチジルエタノールア ミン又はその混合物である、請求の範囲第5項に記載の組成物。 7.乳化剤が約0.2〜5%の量で存在する、請求の範囲第5項に記載の組成物 。 8.界面活性剤が、単数又は複数のヒドロキシル基を含む有機化合物の非イオン 性アルキレンオキシド凝縮物である、請求の範囲第1項に記載の組成物。 9.界面活性剤がエトキシル化アルコール又はエステル化合物である、請求の範 囲第8項に記載の組成物。 10.非イオン性界面活性剤が約0.2〜5%の量で存在する、請求の範囲第9 項に記載の組成物。 11.0.5〜5%の量で有効成分を含む、請求の範囲第1項に記載の組成物。 12.第1の成分が、基本的に水不溶性の油性液体の形の有効成分を含んでいる 、請求の範囲第1項に記載の組成物。 13.有効成分がもう1つの油性液体と共に存在している、請求の範囲第12項 に記載の組成物。 14.第1の成分が、油性液体内に少なくとも部分的に溶解又は分散した、固形 でかつ基本的に水不溶性又はわずかに水溶性の物質の形をした有効成分を含んで いる、請求の範囲第1項に記載の組成物。 15.液滴が乳剤の油相を形成している状態で水中油型乳剤の連続相を形成する 水性成分をさらに含んでいる、請求の範囲第1項に記載の組成物。 16.組成物の均質性を促進するのに充分な量で分散増強剤をさらに含んでいる 、請求の範囲第1項に記載の組成物。 17.組成物に対し半固形の形状を付与するのに充分な量で粘度増強剤をさらに 含んでいる請求の範囲第1項に記載の組成物。 18.粘度増強剤が、生理学的に受容可能な有機又は無機増稠剤である、請求の 範囲第17項に記載の組成物。 19.粘度増強剤が、高分子量の有機化合物を含む有機増稠剤であるか又はコロ イド粒子を含む無機増稠剤である、請求の範囲第18項に記載の組成物。 20.組成物が局所的に皮ふに塗布された後、皮ふを通しての組成物の浸透を増 強するのに充分な量で皮ふ浸透増強剤をさらに含んでいる、請求の範囲第1項に 記載の組成物。 22.皮ふ浸透増強剤がDMSO、デシルメチルスルフオキシド、N−ドデシル ピロリドン、デカノール、ドデカノール又は有機酸である、請求の範囲第20項 に記載の組成物。 23.有効成分が少なくとも1つのステロイド、非ステロイド系抗炎症薬、抗生 物質、精神安定剤、鎮静剤、抗ヒスタミン薬、抗真菌剤、抗ウィルス薬、消毒薬 、抗乾癬薬、免疫抑制剤、血管拡張剤、血管収縮剤又は局所麻酔剤である、請求 の範囲第11項に記載の組成物。 24,有機成分がクロトリマゾール、ビフォナゾール、テトラサイクリン、ミコ ナゾール、トリアムシノロン、アンフォテリシンB、ゲンタマイシン、ヒドロコ ルチゾン、ヨードクスリジン、ジフェンヒドラミン、ミノクシジル、リドカイン 、テトラカイン及びクリンダマイシンである、請求の範囲第23項に記載の組成 物。 25.請求の範囲第11項に記載の組成物を処方すること及び患者の皮ふにこの 組成物を局所的に塗布することを含む、増強された局所的及び/又は経皮性の全 身的効果のための方法において、組成物がより大きいサイズの液滴をもつ同じ組 成物と比較して増強された局所的及び/又は経皮性の全身的効果を提供する方法 。 26.組成物を処方する前に、有効成分を親油性ペプチド、プロスタノイド、プ ロスタノイド作動薬、プロスタノイド拮抗薬、多価不飽和脂肪酸又は抗真菌剤と なるよう選択することがさらに含まれる、請求の範囲第25項に記載の方法。 27.組成物を処方する前に、有効成分をバルビツール酸塩、べンゾジアゼピン 、ケトチフェン、フェニトイン、フェノチアジン、シクロスポリン、フィトチグ ミン、タクリン、ジフェノキシレート、シクロフェナック、デキサメタゾン、プ ロスタグランジン、フェジピン、ニトログリセリン、アトロピン、ベラパミル、 フェンタニル、ミコナゾール又はケトコナゾールとなるよう選択することをさら に含む、請求の範囲第25項に記載の方法。 28.有効成分がビタミンA、ビタミンE、エイコサペンタエン酸、レチノイド 、カロチン又は過酸化ベンゾイルとなるよう選択することをさらに含む、請求の 範囲第25項に記載の方法。 29.請求の範囲第11項に記載の組成物を処方すること及びこの組成物を患者 の皮ふに局所的に塗布することを含む、患者の皮ふの治療のための方法において 、組成物が、アトピー性皮ふ炎、乾癬、アクネ(座瘡)及びその他のタイプの皮 ふ炎又はウィルス、真菌又は細菌による皮ふ感染を緩和、減少又は予防するべく 、さらに大きなサイズの液滴をもつ同じ組成物に比べて増強された局所的及び/ 又は経皮性の全身的効果を提供している、治療方法。 30.請求の範囲第11項に記載の組成物を処方すること及び患者の皮ふにこの 組成物を局所的に塗布することを含む、局所的な炎症反応を誘発する調合薬によ って生成される局所的過敏を低減させるための方法において、組成物が、さらに 大きいサイズの液滴を有する同じ組成物に比べて増強された局所的及び/又は経 皮性の全身的効果を提供している方法。 31.請求の範囲第11項に記載の組成物を処方すること及びこの組成物を患者 に局所的に塗布することを含む、局所麻酔又は無痛覚を達成するため又は全身無 痛覚を提供するための方法。 32.請求の範囲第11項に記載の組成物及び上に組成物を保持するためのサポ ートを含む、有効成分を局所的かつ経皮的に塗布するための用品において、この サポートには患者の皮ふに用品を固定するための接着剤が含まれている用品。 33.有効成分がステロイド、ニコチン又はニトログリセリンである、請求の範 囲第32項に記載の用品。 34.閉鎖包帯又は粘着性バッチの形をした請求の範囲第32項に記載の用品。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10138792A IL101387A (en) | 1992-03-26 | 1992-03-26 | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
US36116 | 1993-03-23 | ||
US08/036,116 US6004566A (en) | 1992-03-26 | 1993-03-23 | Topical and transdermal delivery system utilizing submicron oil spheres |
PCT/US1993/002800 WO1993018752A1 (en) | 1992-03-26 | 1993-03-25 | Topical and transdermal delivery system utilizing submicron oil spheres |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005232365A Division JP2006008700A (ja) | 1993-03-23 | 2005-08-10 | 超微小油球体を用いての局部用及び経皮用投与システム |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07505368A true JPH07505368A (ja) | 1995-06-15 |
JP4173533B2 JP4173533B2 (ja) | 2008-10-29 |
Family
ID=26322424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51683693A Expired - Fee Related JP4173533B2 (ja) | 1992-03-26 | 1993-03-25 | 超微小油球体を用いての局部用及び経皮用投与システム |
Country Status (12)
Country | Link |
---|---|
US (1) | US6004566A (ja) |
EP (1) | EP0671903B1 (ja) |
JP (1) | JP4173533B2 (ja) |
AT (1) | ATE210425T1 (ja) |
AU (1) | AU684460B2 (ja) |
CA (2) | CA2590810A1 (ja) |
DE (1) | DE69331335T2 (ja) |
DK (1) | DK0671903T3 (ja) |
ES (1) | ES2169042T3 (ja) |
IL (2) | IL101387A (ja) |
WO (1) | WO1993018752A1 (ja) |
ZA (1) | ZA932170B (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003212776A (ja) * | 2002-01-05 | 2003-07-30 | Pacific Corp | 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物 |
JP2003525257A (ja) * | 2000-03-02 | 2003-08-26 | メーヌラブ | 脂質ナノカプセル、その製造方法、および医薬としての使用 |
WO2009063962A1 (ja) * | 2007-11-16 | 2009-05-22 | Techno Guard Co. Ltd. | 薬物含有脂肪乳剤およびその製造方法 |
JP2011500863A (ja) * | 2007-10-30 | 2011-01-06 | ノバルティス アーゲー | 局所用組成物 |
JP2011523950A (ja) * | 2008-05-23 | 2011-08-25 | プロファウンド・エイジア・テクノロジー・リミテッド | 脂肪低下のためのペオニフロリン製剤およびその使用 |
JP2012523408A (ja) * | 2009-04-08 | 2012-10-04 | カディラ・ヘルスケア・リミテッド | ジクロフェナクの安定な医薬組成物 |
JP2017066057A (ja) * | 2015-09-28 | 2017-04-06 | 株式会社ポーラファルマ | 皮膚外用剤及びその製造方法並びに有効成分の放出性の向上方法及び放出性の評価方法 |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ260018A (en) * | 1994-03-03 | 1995-10-26 | Bomac Lab Ltd | Benzimidazole compositions and anthelmintic compositions |
GB9409778D0 (en) | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
AT408067B (de) * | 1995-03-17 | 2001-08-27 | Gebro Pharma Gmbh | Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung |
EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
AU7689996A (en) * | 1995-12-12 | 1997-07-03 | Vesifact Ag | Cortisone spray for topical administration |
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
KR100294084B1 (ko) * | 1998-06-02 | 2001-09-22 | 성재갑 | 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형 |
EP0858805A3 (en) * | 1997-02-13 | 1998-09-02 | National Research Institute of Chinese Medicine | Transdermal preparations of oxicams |
TWI241915B (en) | 1998-05-11 | 2005-10-21 | Ciba Sc Holding Ag | A method of preparing a pharmaceutical end formulation using a nanodispersion |
US6946144B1 (en) * | 1998-07-08 | 2005-09-20 | Oryxe | Transdermal delivery system |
US7220427B2 (en) * | 1998-07-08 | 2007-05-22 | Oryxe | Mixture for transdermal delivery of low and high molecular weight compounds |
IT1303692B1 (it) * | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
FR2785803B1 (fr) * | 1998-11-17 | 2005-03-25 | Sanofi Sa | Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes |
IL138616A0 (en) * | 2000-09-21 | 2001-10-31 | J P M E D Ltd | Oil in glycerin emulsion |
US7393548B2 (en) * | 1999-03-22 | 2008-07-01 | J.P. M.E.D. Ltd. | Nano oil in glycerin emulsion |
EP1169016A1 (en) * | 1999-04-14 | 2002-01-09 | The Procter & Gamble Company | Transparent composition |
IT1312088B1 (it) * | 1999-04-21 | 2002-04-04 | Altergon Sa | Cerotto per uso topico contenente eparina e diclofenac. |
US6515029B1 (en) | 1999-04-23 | 2003-02-04 | Kimberly-Clark Worldwide, Inc. | Absorbent article having a hydrophilic lotionized bodyside liner |
ES2221624T3 (es) * | 1999-08-26 | 2005-01-01 | Ganeden Biotech, Inc. | Uso de aceite de emu como vehiculo para mediaciones antifungicas, antibacterianas y antiviricas. |
WO2001028519A1 (de) * | 1999-10-20 | 2001-04-26 | Vesifact Ag | Mikroemulsion-prekonzentrate und mikroemulsionen |
US6565879B1 (en) | 1999-12-16 | 2003-05-20 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US6558695B2 (en) | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
US20050037073A1 (en) * | 2000-01-13 | 2005-02-17 | Alpharx Inc. | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof |
JP2003527411A (ja) * | 2000-03-23 | 2003-09-16 | コラボレイティヴ・テクノロジーズ・インコーポレーテッド | 生理学上活性な成分を含有する高圧/高剪断分散物を調製する方法 |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
FR2811564B1 (fr) * | 2000-07-13 | 2002-12-27 | Oreal | Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique |
US6503526B1 (en) | 2000-10-20 | 2003-01-07 | Kimberly-Clark Worldwide, Inc. | Absorbent articles enhancing skin barrier function |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
FR2823117A1 (fr) * | 2000-11-14 | 2002-10-11 | Pharmascience Lab | Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans |
US20020165286A1 (en) * | 2000-12-08 | 2002-11-07 | Hanne Hedeman | Dermal anti-inflammatory composition |
US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
US20020128615A1 (en) | 2000-12-22 | 2002-09-12 | Tyrrell David John | Absorbent articles with non-aqueous compositions containing anionic polymers |
US6749860B2 (en) | 2000-12-22 | 2004-06-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with non-aqueous compositions containing botanicals |
JP4098967B2 (ja) * | 2001-04-18 | 2008-06-11 | 花王株式会社 | ダイラタンシー組成物 |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
RU2286801C2 (ru) | 2001-05-01 | 2006-11-10 | Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук | Двухфазные биоадгезионные композиции, абсорбирующие воду |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
ATE438418T1 (de) | 2001-05-01 | 2009-08-15 | Av Topchiev Inst Petrochemical | Hydrogel-zusammensetzungen |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US20030027833A1 (en) * | 2001-05-07 | 2003-02-06 | Cleary Gary W. | Compositions and delivery systems for administration of a local anesthetic agent |
US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
DE10164531A1 (de) * | 2001-12-31 | 2003-07-17 | Pharmatech Gmbh | Zubereitung zur Oberflächenanästhesie der Haut |
DE10200578A1 (de) * | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
US6579543B1 (en) * | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
IL157535A0 (en) * | 2003-08-21 | 2004-03-28 | Topimed Ltd | Preparations for the prevention of skin atrophy |
US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
CN1852690B (zh) * | 2003-09-19 | 2010-04-14 | 制药技术有限公司 | 药物输送系统 |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
CA2554649C (en) | 2004-01-30 | 2015-10-27 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
WO2006017807A2 (en) | 2004-08-05 | 2006-02-16 | Corium International, Inc. | Adhesive composition |
KR100623013B1 (ko) * | 2004-09-04 | 2006-09-19 | 김영대 | 나노에멀션, 그의 용도 및 제조방법 |
WO2006036936A2 (en) * | 2004-09-27 | 2006-04-06 | Bridge Pharma, Inc. | The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
US20060079558A1 (en) * | 2004-09-27 | 2006-04-13 | Bridge Pharma. Inc. | R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
DE102004059613A1 (de) * | 2004-12-10 | 2006-06-14 | Liedtke, Rainer K., Dr. | Zusammensetzung und Methode einer topischen Therapie von Neurodermitis |
US20060222687A1 (en) * | 2005-04-01 | 2006-10-05 | Carter Stephen G | Topical anesthetic |
BRPI0608599A2 (pt) * | 2005-05-09 | 2010-01-19 | Drugtech Corp | composiÇÕes farmacÊuticas de liberaÇço modificada |
US20070015691A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
JP2009522360A (ja) * | 2006-01-05 | 2009-06-11 | ドラッグテック コーポレイション | 組成物およびその使用方法 |
BRPI0620907A2 (pt) * | 2006-01-05 | 2011-11-29 | Drugtech Corp | composição farmacêutica, sistema de distribuição de droga vaginal e uso da composição farmacêutica |
WO2007118653A2 (de) * | 2006-04-11 | 2007-10-25 | Koko Kosmetikvertrieb Gmbh & Co. Kg | Nanopartikel, enthaltend nicotin und/oder cotinin, dispersionen und die verwendung derselben |
WO2008011161A2 (en) * | 2006-07-21 | 2008-01-24 | Bridge Pharma, Inc. | Dermal anesthetic compounds |
CA2666398C (en) | 2006-10-17 | 2015-08-18 | Ed Kisak | Diclofenac gel |
US20080160077A1 (en) * | 2006-11-27 | 2008-07-03 | Zymes, Llc | Soft Gel Formulations |
EP2091516A2 (en) | 2006-12-01 | 2009-08-26 | Anterios, Inc. | Peptide nanoparticles and uses therefor |
CN101848702B (zh) | 2006-12-01 | 2013-07-17 | 安特里奥公司 | 两亲实体纳米粒子 |
US9918934B2 (en) | 2006-12-12 | 2018-03-20 | Edgar Joel Acosta-Zara | Linker-based lecithin microemulsion delivery vehicles |
ES2660906T3 (es) | 2007-05-31 | 2018-03-26 | Anterios, Inc. | Nanopartículas de ácido nucleico y usos de las mismas |
FR2934955B1 (fr) | 2008-08-14 | 2011-07-08 | Commissariat Energie Atomique | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions |
FR2934953B1 (fr) | 2008-08-14 | 2011-01-21 | Commissariat Energie Atomique | Nanoemulsions de nanocristaux |
FR2934954B1 (fr) | 2008-08-14 | 2011-07-22 | Commissariat Energie Atomique | Emulsion fluorescente de vert d'indocyanine |
EP2387394B1 (en) | 2009-01-14 | 2018-05-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
US9789123B2 (en) | 2010-10-21 | 2017-10-17 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
US9636353B2 (en) | 2010-10-21 | 2017-05-02 | Cadila Healthcare Limited | Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene |
WO2012053009A2 (en) | 2010-10-21 | 2012-04-26 | Cadila Healthcare Limited | Pharmaceutical compositions comprising skin whitening agents |
MX2013004248A (es) | 2010-10-21 | 2013-07-22 | Cadila Healthcare Ltd | Composiciones farmaceuticas topicas que comprenden etodolaco. |
MX2013004296A (es) | 2010-10-21 | 2013-09-26 | Cadila Healthcare Ltd | Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis. |
WO2012053012A2 (en) | 2010-10-21 | 2012-04-26 | Cadila Healthcare Limited | Topical pharmaceutical compositions comprising tfflocolchicoside |
US10028972B2 (en) | 2010-10-21 | 2018-07-24 | Cadila Healthcare Limited | Pharmaceutical compositions of anti-acne agents |
US9254257B2 (en) | 2010-10-21 | 2016-02-09 | Cadila Healthcare Limited | Method for treatment of acne using pharmaceutical compositions of clindamycin |
WO2012127496A1 (en) * | 2011-03-01 | 2012-09-27 | Cadila Healthcare Limited | Stable pharmaceutical compositions of lornoxicam or salts thereof |
WO2013014680A1 (en) * | 2011-07-28 | 2013-01-31 | Cadila Healthcare Limited | Method for treatment of pain and inflammation |
US8936814B2 (en) * | 2012-11-30 | 2015-01-20 | Zuri A. Murrell | Skin cream |
DE102014102400A1 (de) * | 2014-02-25 | 2015-08-27 | Reinhard Caliebe | Topische kosmetische oder pharmazeutische Zusammensetzung |
WO2015147296A1 (ja) * | 2014-03-27 | 2015-10-01 | 株式会社ポーラファルマ | 乳化剤形の組成物の製造方法 |
CA3050535C (en) * | 2014-12-15 | 2021-11-09 | Richard Clark Kaufman | Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of anti-inflammatory nutraceuticals |
US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
US10596117B1 (en) * | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
EP3349717A4 (en) | 2015-09-17 | 2019-04-17 | JRX Biotechnology, Inc. | APPROACHES TO IMPROVE HYDRATION OR HUMIDIFICATION OF THE SKIN |
US10172838B1 (en) | 2016-03-15 | 2019-01-08 | Florida A&M University | Self-emulsifying formulation of CARP-1 functional mimetics |
CN110198703A (zh) | 2016-11-21 | 2019-09-03 | 艾里奥治疗公司 | 大试剂的透皮递送 |
RU2765470C1 (ru) * | 2021-03-23 | 2022-01-31 | Иршад Султанович Шарафутдинов | Антибактериальное средство в форме геля на основе гентамицина и производного 2(5н)-фуранона |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7713618L (sv) * | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Lokalanestetisk blandning |
EP0014509A3 (en) * | 1979-02-08 | 1981-02-11 | THE PROCTER & GAMBLE COMPANY | Skin conditioning compositions |
JPS57171912A (en) * | 1981-04-14 | 1982-10-22 | Sumitomo Chem Co Ltd | Cream |
FR2520253A1 (fr) * | 1982-01-28 | 1983-07-29 | Oreal | Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique |
US4613330A (en) * | 1982-11-26 | 1986-09-23 | Michelson Paul E | Delivery system for desired agents |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
DE68917544T2 (de) * | 1988-06-20 | 1994-12-15 | Shiseido Co Ltd | Durchsichtiges Präparat. |
US5039527A (en) * | 1989-02-24 | 1991-08-13 | Medicontrol Corporation | Hexamethylmelamine containing parenteral emulsions |
AU614465B2 (en) * | 1989-04-05 | 1991-08-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
JPH0344322A (ja) * | 1989-07-13 | 1991-02-26 | Shiseido Co Ltd | マイクロエマルション製剤及びその製造法 |
FR2655542B1 (fr) * | 1989-12-13 | 1994-02-11 | Oreal | Composition cosmetique pour application topique contenant des huiles essentielles. |
CA2052950A1 (en) * | 1990-10-10 | 1992-04-11 | David P. Evitts | Aqueous ophthalmic microemulsions of tepoxalin |
AU658608B2 (en) * | 1991-03-25 | 1995-04-27 | Astellas Pharma Europe B.V. | Topical preparation containing a suspension of solid lipid particles |
WO1993015736A1 (en) * | 1992-02-18 | 1993-08-19 | Pharmos Corp. | Dry compositions for preparing submicron emulsions |
IL101241A (en) * | 1992-03-16 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier |
-
1992
- 1992-03-26 IL IL10138792A patent/IL101387A/en active IP Right Grant
-
1993
- 1993-03-23 US US08/036,116 patent/US6004566A/en not_active Expired - Fee Related
- 1993-03-25 ES ES93908578T patent/ES2169042T3/es not_active Expired - Lifetime
- 1993-03-25 CA CA002590810A patent/CA2590810A1/en not_active Abandoned
- 1993-03-25 WO PCT/US1993/002800 patent/WO1993018752A1/en active IP Right Grant
- 1993-03-25 DE DE69331335T patent/DE69331335T2/de not_active Expired - Fee Related
- 1993-03-25 JP JP51683693A patent/JP4173533B2/ja not_active Expired - Fee Related
- 1993-03-25 DK DK93908578T patent/DK0671903T3/da active
- 1993-03-25 EP EP93908578A patent/EP0671903B1/en not_active Expired - Lifetime
- 1993-03-25 AU AU39352/93A patent/AU684460B2/en not_active Ceased
- 1993-03-25 AT AT93908578T patent/ATE210425T1/de not_active IP Right Cessation
- 1993-03-25 CA CA002132736A patent/CA2132736C/en not_active Expired - Fee Related
- 1993-03-26 ZA ZA932170A patent/ZA932170B/xx unknown
-
1999
- 1999-05-12 IL IL12992199A patent/IL129921A/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003525257A (ja) * | 2000-03-02 | 2003-08-26 | メーヌラブ | 脂質ナノカプセル、その製造方法、および医薬としての使用 |
JP2003212776A (ja) * | 2002-01-05 | 2003-07-30 | Pacific Corp | 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物 |
JP4549625B2 (ja) * | 2002-01-05 | 2010-09-22 | 株式會社アモーレパシフィック | 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物 |
JP2011500863A (ja) * | 2007-10-30 | 2011-01-06 | ノバルティス アーゲー | 局所用組成物 |
WO2009063962A1 (ja) * | 2007-11-16 | 2009-05-22 | Techno Guard Co. Ltd. | 薬物含有脂肪乳剤およびその製造方法 |
JP2011523950A (ja) * | 2008-05-23 | 2011-08-25 | プロファウンド・エイジア・テクノロジー・リミテッド | 脂肪低下のためのペオニフロリン製剤およびその使用 |
JP2012523408A (ja) * | 2009-04-08 | 2012-10-04 | カディラ・ヘルスケア・リミテッド | ジクロフェナクの安定な医薬組成物 |
JP2017066057A (ja) * | 2015-09-28 | 2017-04-06 | 株式会社ポーラファルマ | 皮膚外用剤及びその製造方法並びに有効成分の放出性の向上方法及び放出性の評価方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2132736C (en) | 2007-09-11 |
AU3935293A (en) | 1993-10-21 |
IL101387A (en) | 1999-11-30 |
JP4173533B2 (ja) | 2008-10-29 |
WO1993018752A1 (en) | 1993-09-30 |
EP0671903A1 (en) | 1995-09-20 |
ZA932170B (en) | 1993-10-28 |
IL129921A (en) | 2004-09-27 |
EP0671903B1 (en) | 2001-12-12 |
ES2169042T3 (es) | 2002-07-01 |
AU684460B2 (en) | 1997-12-18 |
US6004566A (en) | 1999-12-21 |
CA2590810A1 (en) | 1993-09-30 |
DE69331335T2 (de) | 2002-08-08 |
DK0671903T3 (da) | 2002-04-15 |
IL101387A0 (en) | 1992-11-15 |
DE69331335D1 (de) | 2002-01-24 |
CA2132736A1 (en) | 1993-09-30 |
EP0671903A4 (en) | 1996-01-17 |
IL129921A0 (en) | 2000-02-29 |
ATE210425T1 (de) | 2001-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4173533B2 (ja) | 超微小油球体を用いての局部用及び経皮用投与システム | |
US6113921A (en) | Topical and transdermal delivery system utilizing submicron oil spheres | |
JP7412105B2 (ja) | ナノエマルジョン送達系の組成物 | |
Azeem et al. | Microemulsions as a surrogate carrier for dermal drug delivery | |
Kogan et al. | Microemulsions as transdermal drug delivery vehicles | |
US10709748B2 (en) | Encapsulated cannabinoid formulations for transdermal delivery | |
Schwarz et al. | Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams | |
Paolino et al. | Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability | |
JP2947668B2 (ja) | 固体脂質粒子の懸濁液を含有する局所製剤 | |
AU2014359195B2 (en) | Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics | |
Friedman et al. | Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs | |
KR100654846B1 (ko) | 나노사이즈의 리포좀과 수중유상 에멀젼을 포함하는화장료 조성물 및 그 제조방법 | |
JPH09510692A (ja) | コルチコステロイドを含む油中水型ローション | |
JP2007308430A (ja) | ニキビ治療剤 | |
Klang et al. | Nanoemulsions in dermal drug delivery | |
WO2021229578A1 (en) | Compositions for delivery of bioactive agents into hair follicles | |
JP2001097859A (ja) | ウフェナマート含有乳化製剤 | |
US11197831B2 (en) | Compositions comprising at least one dispersed active principle and lipid microcapsules | |
WO2022140467A1 (en) | Topical compositions and methods of treating skin diseases and conditions with such compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040204 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040322 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040430 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050810 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20051013 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20060126 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070619 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070622 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080317 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080321 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080618 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080814 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110822 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |